title: [Criteria and best clinical practice guidelines for first intradetrusor injection of botulinum toxin type A to treat neurogenic detrusor overactivity].
abstract: Botulinum toxin A intradetrusor injections have revolutionised the treatment of neurogenic detrusor overactivity. Based on a systematic literature review, the french speaking group of neuro-urology (Genulf) propose clinical guidelines concerning the indications of the first injection.
authors.affiliation: Service de médecine physique et de réadaptation neurologique, hôpital Saint-Jacques, CHU de Nantes, 85, rue Saint-Jacques, 44093 Nantes cedex, France. brigitte.perrouinverbe@chu-nantes.fr
authors.forename: B
authors.initials: B
authors.lastname: Perrouin-Verbe
authors.forename: A
authors.initials: A
authors.lastname: Ruffion
authors.forename: X
authors.initials: X
authors.lastname: Gamé
authors.forename: P
authors.initials: P
authors.lastname: Denys
authors.forename: J
authors.initials: J
authors.lastname: Kerdraon
authors.forename: G
authors.initials: G
authors.lastname: Karsenty
authors.forename: M
authors.initials: M
authors.lastname: de Sèze
authors.forename: F
authors.initials: F
authors.lastname: Haab
authors.forename: C
authors.initials: C
authors.lastname: Saussine
authors.forename: J-M
authors.initials: JM
authors.lastname: Soler
authors.forename: G
authors.initials: G
authors.lastname: Amarenco
authors.forename: E
authors.initials: E
authors.lastname: Chartier-Kastler
mesh_terms: D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy*
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A